A CreER-based random induction strategy for modeling translocation- associated sarcomas in mice

Cancer Research

Volumn 69, Issue 8, 2009, Pages 3657-3664

  Haldar, Malay ^a   Hedberg, Matthew L ^a   Hockin, Matthew F ^a   Capecchi, Mario R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; HYBRID PROTEIN; SYT SSX2 FUSION PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CLINICAL FEATURE; CONTROLLED STUDY; EMBRYO; HISTOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL SARCOMA;

ANIMALS; INTEGRASES; MICE; ONCOGENE PROTEINS, FUSION; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 65949109502     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4127     Document Type: Article

References (24)

1. Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors. 4th ed. Mosby, Inc; 2001.
2. Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat. Rev. Cancer 2007; 7: 645-58. (Pubitemid 47327410)
3. Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Ore: a tool for temporally regulated gene activation/inactiva-tion in the mouse. Dev Biol. 2002; 244: 305-18. (Pubitemid 34450645)
4. Haldar M, Hancock JD, Coffin CM, Lessnick SL, Capecchi MR. A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell 2007; 11: 375-88. (Pubitemid 46518310)
5. Macatee TL, Hammond RP, Arenkiel BR, Francis L, Frank DU, Moon AM. Ablation of specific expression domains reveals discrete functions of ectoderm- and endoderm-derived FGF8 during cardiovascular and pharyngeal development Development 2003; 130: 6361-74. (Pubitemid 38008833)
6. Akiyama H, Kim JE, Nakashima K. et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl. Acad. Sci. U S A 2005; 102: 14665-70. (Pubitemid 41457113)
7. Yu K, Xu J, Liu Z. et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 2003; 130: 3063-74. (Pubitemid 36857252)
8. Licht AH, Raab S, Hofmann U, Breier G. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice. Dev Dyn 2004; 229: 312-8. (Pubitemid 38140469)
9. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Riol 2001; 230: 230-42. (Pubitemid 32171420)
10. Tranche F, Kellendonk C, Kretz O. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 1999; 23: 99-103. (Pubitemid 29418797)
11. Srinivas S, Watanabe T, Lin CS. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol. 2001; 1: 4. (Pubitemid 38883775)
12. Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004; 10: 310-5. (Pubitemid 38667624)
13. Badea TC, Wang Y, Nathans J. A noninvasive genetic /pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J. Neurosci 2003; 23: 2314-22. (Pubitemid 36368919)
14. Kemp R, Ireland H, Clayton E, Houghton C, Howard L, Winton DJ. Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity. Nucleic Acids Res 2004; 32: e92
15. Torchia EC, Boyd K, Rehg JE, Qu C, Raker SJ. EWS /FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice. Mol. Cell Biol. 2007; 27: 7918-34. (Pubitemid 350086425)
16. Mutlu AD, Cavallin LE, Vincent L. et al. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 2007; 11: 245-58. (Pubitemid 46357638)
17. Guo Z, Dose M, Kovalovsky D. et al. β-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood 2007; 109: 5463-72. (Pubitemid 46890570)
18. Hedlund M, Ng E, Varki A, Varki NM. α 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res 2008; 68: 388-94
19. Li Z, Tognon CE, Godinho FJ. et al. ETV6-3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of API complex. Cancer Cell 2007; 12: 542-58. (Pubitemid 350199073)
20. Carrasco DR, Sukhdeo K, Protopopova M. et al. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell 2007; 11: 349-60. (Pubitemid 46518314)
21. Walkley CR, Qudsi R, Sankaran VG. et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 2008; 22: 1662-76.
22. Soriano P, Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-1. (Pubitemid 29036285)
23. Wu S, Wu Y, Capecchi MR. Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo. Development 2006; 1133: 581-90.
24. Johnson L, Mercer K, Greenbaum D. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410: 1111-6. (Pubitemid 32391044)